Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Biology Reports|November 14, 2019
Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patientsMarta Viana-Pereira, Daniel Antunes Moreno, Paulo Linhares, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 28, 2018
Genetic variants of vascular endothelial growth factor predict risk and survival of gliomasPaulo Linhares, Marta Viana-Pereira, Mónica Ferreira, et al.
Cancer Genetics and Cytogenetics|December 11, 2007
TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomasVítor Lima-Ramos, Luís Pacheco-Figueiredo, Sandra Costa, et al.
Cureus|October 25, 2024
Impact of Suppressor of Mothers Against Decapentaplegic (SMAD) 7 Gene Single Nucleotide Polymorphisms on Colorectal Cancer Risk and PrognosisMaurício Peixoto, Marta Viana-Pereira, Maria Júlia Amorim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 28, 2015
Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosisJoana Vieira de Castro, Céline S Gonçalves, Sandra Costa, et al.
Ciencia & Saude Coletiva|October 15, 2015
[The use, care and policy of complementary and integrative practices in primary health care]Octávio Augusto Contatore, Nelson Filice de Barros, Melissa Rossati Durval, et al.
Journal of Neuro-Oncology|January 14, 2017
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosisAna Xavier-Magalhães, Ana I Oliveira, Joana Vieira de Castro, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2019
Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2Márcia Santos Pereira, Sónia Pires Celeiro, Ângela Margarida Costa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2011
Impact of EGFR genetic variants on glioma risk and patient outcomeBruno Marques Costa, Marta Viana-Pereira, Ricardo Fernandes, et al.
Oncology Reports|April 30, 2010
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre studyBruno M Costa, Cláudia Caeiro, Inês Guimarães, et al.
Pageof 1